![](/img/cover-not-exists.png)
GS-0976 (Firsocostat): an investigational liver-directed acetyl-CoA carboxylase (ACC) inhibitor for the treatment of non-alcoholic steatohepatitis (NASH)
Alkhouri, Naim, Lawitz, Eric, Noureddin, Mazen, DeFronzo, Ralph, Shulman, Gerald I.Language:
english
Journal:
Expert Opinion on Investigational Drugs
DOI:
10.1080/13543784.2020.1668374
Date:
September, 2019
File:
PDF, 1.71 MB
english, 2019